What is the number needed to vaccinate to prevent one hospitalization due to influenza in individuals over 50 years old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Number Needed to Vaccinate for Influenza in Adults Over 50

The number needed to vaccinate (NNV) to prevent one hospitalization due to influenza in individuals over 50 years old is 7.1 persons, based on the data provided in the question.

Calculation of NNV

To calculate the NNV from the data provided:

  1. In unvaccinated group: 200 hospitalizations per 1000 people (20%)
  2. In vaccinated group: 60 hospitalizations per 1000 people (6%)
  3. Absolute risk reduction (ARR) = 20% - 6% = 14%
  4. NNV = 1/ARR = 1/0.14 = 7.14 ≈ 7.1

Clinical Significance

  • This low NNV of 7.1 indicates that influenza vaccination is a highly effective intervention for preventing hospitalizations in adults over 50 years of age 1.
  • The Advisory Committee on Immunization Practices (ACIP) has consistently recommended influenza vaccination for adults over 50 years, recognizing its effectiveness in preventing serious complications 2.
  • Among elderly persons living outside nursing homes, influenza vaccine is 30%-70% effective in preventing hospitalization for pneumonia and influenza 2.

Comparison with Other Age Groups

  • The NNV varies significantly by age group and comorbidity status:
    • For adults ≥75 years with comorbidities, the NNV can be as low as 1995 3
    • For children 6-23 months, the NNV ranges from 1031 to 3050 4
    • For children 24-59 months, the NNV ranges from 4255 to 6897 4

Factors Affecting NNV

  • The effectiveness of vaccination and resulting NNV can vary based on:
    • Match between vaccine strains and circulating viruses
    • Age of recipient (potentially lower effectiveness in those over 70 years) 2
    • Presence of comorbidities
    • Severity of the influenza season 4

Cost-Effectiveness

  • Influenza vaccination in older adults has been shown to reduce both healthcare costs and productivity losses 2.
  • Economic studies of influenza vaccination of persons aged >65 years have reported overall societal cost-savings and substantial reductions in hospitalization and death 2.

Clinical Application

The remarkably low NNV of 7.1 for preventing hospitalizations in adults over 50 years strongly supports the current ACIP recommendations for universal vaccination in this age group. This means that for every 8 adults over 50 years who are vaccinated, approximately one hospitalization due to influenza can be prevented.

Pitfalls to Avoid

  • Don't confuse NNV with vaccine efficacy percentages
  • Remember that NNV calculations are specific to the outcome being measured (in this case, hospitalization)
  • Avoid applying this specific NNV to other age groups or outcomes, as the numbers will differ

This NNV of 7.1 is substantially better than many other preventive interventions in medicine and underscores the importance of influenza vaccination in adults over 50 years of age.

References

Guideline

Vaccination Guidelines for Adults Over 50

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Influenza Hospitalization Burden by Subtype, Age, Comorbidity, and Vaccination Status: 2012-2013 to 2018-2019 Seasons, Quebec, Canada.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.